Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Nature Communications
|
September 17, 2021
Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits
Jon Palacios-Filardo, Matt Udakis, Giles A Brown, et al.
Heliyon
|
June 30, 2021
Characterisation of inverse agonism of the orphan-G protein-coupled receptor GPR52 by cannabinoid ligands Cannabidiol and O-1918
Lisa A Stott, Cheryl A Brighton, Jason Brown, et al.
Journal of Medicinal Chemistry
|
July 31, 2015
Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile)
John A Christopher, Sarah J Aves, Kirstie A Bennett, et al.
Journal of Medicinal Chemistry
|
December 21, 2019
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas, Ammar A E Ali, Kirstie A Bennett, et al.
Cell
|
November 25, 2021
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease
Alastair J H Brown, Sophie J Bradley, Fiona H Marshall, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Nature Communications
|
September 17, 2021
Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits
Jon Palacios-Filardo, Matt Udakis, Giles A Brown, et al.
Heliyon
|
June 30, 2021
Characterisation of inverse agonism of the orphan-G protein-coupled receptor GPR52 by cannabinoid ligands Cannabidiol and O-1918
Lisa A Stott, Cheryl A Brighton, Jason Brown, et al.
Journal of Medicinal Chemistry
|
July 31, 2015
Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile)
John A Christopher, Sarah J Aves, Kirstie A Bennett, et al.
Journal of Medicinal Chemistry
|
December 21, 2019
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas, Ammar A E Ali, Kirstie A Bennett, et al.
Cell
|
November 25, 2021
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease
Alastair J H Brown, Sophie J Bradley, Fiona H Marshall, et al.
Page
of 2